Search
CELL BANK Website

Back Back
RCB1129 : TGBC1TKB  update : 2018/07/31
CommentJapanese gallbadder carcinoma metastated to lymph node from the same patient of TGBC2TKB. Application consideration
Comment from the depositor
Terms and conditionsBasically, there is no restriction regarding academic use.
Remarks
Order Form Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, Category I and II, depending on the sort of user institutions and the purposes of use.Please use an appropriate MTA(to see).In case of Restriction "a" or "f", please contact RIKEN BRC(cellbank.brc@riken.jp) regarding any kind of for-profit use.
Basic information Depositor Todoroki, T. & Ohno, T.
Originator Todoroki, T. & Ohno, T. & Kim, B.
Year of deposit 1994
Another name TGBC-1, Na
Animal human < Mammals
Genus Homo
Species sapiens
Race Japanese
Gender Female
Tissue gallbladder, lymph node meta
Metastastatic ability Yes
Metastatsd tissue lymph node
Classification cancer
Year of origin 1994
Lifespan infinite
Morphology epithelial-like
deposit info
lot info
Medium Medium List
Culture type Adherent cells
Medium and additives DMEM (low glucose) + 5% FBS
Antibiotics Free
Passage method 0.25% trypsin
Culture information Passage ratio 1 : 4 split
SC frequency Subculture : once/1-2 weeks, Medium Renewal : 2 times/week
Temperature 37 ℃
CO2 concentration 5 %
Freeze medium Medium + 10% DMSO
Freezing method Slow freezing
Mycoplasma (-)
STR (human) OK
Virus (HIV) (-)
Virus (HBV) (-)
Virus (HCV) (-)
Isozyme LD, NP
Chromosome mode 58-65(65) : 58(5),59(8),60(15),61(16),62(8),63(4)/
Images
deposit info
lot info
Reference information Reference 5
User's Publication 36


To topTop
Reference
3704  Targeting interleukin-4 receptor alpha by hybrid Peptide for novel biliary tract cancer therapy.  Seto 1, Shoda J, Horibe T, Warabi E, Kohno M, Yanagawa T, Bukawa H, Nakanuma Y, Kawakami K.  Int J Hepatol  2014  584650  PubMed ID: 24868471
3707  Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase isozyme 3 in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder.  Miyahara N, Shoda J, Kawamoto T, Furukawa M, Ueda T, Todoroki T, Tanaka N, Matsuo K, Yamada Y, Kohno K, Irimura T.  Clin Cancer Res  2004  10(6):2090-9  PubMed ID: 15041730
3708  Potent in vitro and in vivo antitumor activity of interleukin-4-conjugated Pseudomonas exotoxin against human biliary tract carcinoma.  Ishige K, Shoda J, Kawamoto T, Matsuda S, Ueda T, Hyodo I, Ohkohchi N, Puri RK, Kawakami K.  Int J Cancer  2008  123(12):2915-22  PubMed ID: 18798553
3716  Expression of N-acetylglucosaminyltransferase V in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder.  Onuki K1, Sugiyama H, Ishige K, Kawamoto T, Ota T, Ariizumi S, Yamato M, Kadota S, Takeuchi K, Ishikawa A, Onodera M, Onizawa K, Yamamoto M, Miyoshi E, Shoda J.  J Gastroenterol  2014  49(4):702-14  PubMed ID: 23588887
3718  Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.  Shoda J1, Matsuda A2, Shida T3, Yamamoto M, Nagino M, Tsuyuguchi T, Yasaka T, Tazuma S, Uchiyama K, Unno M, Ohkohchi N, Nakanuma Y, Kuno A, Narimatsu H.  J Gastroenterol  2017  52(2):218-228  PubMed ID: 27358229

To topTop
User's Publication
7134  A potent therapeutics for gallbladder cancer by combinatorial inhibition of the MAPK and mTOR signaling networks.  Mohri D, Ijichi H, Miyabayashi K, Takahashi R, Kudo Y, Sasaki T, Asaoka Y, Tanaka Y, Ikenoue T, Tateishi K, Tada M, Isayama H, Koike K.  J. Gastroenterol.  2015  51:711-21  PubMed ID: 26614007
7273  Acquisition of chemoresistance to gemcitabine is induced by a loss-of-function missense mutation of DCK.  Nakano T, Saiki Y, Kudo C, Hirayama A, Mizuguchi Y, Fujiwara S, Soga T, Sunamura M, Matsumura N, Motoi F, Unno M, Horii A.  Biochem. Biophys. Res. Commun.  2015  464:1084-9  PubMed ID: 26196746
7355  Down-regulation of Immune-related Genes by PSCA in Gallbladder Cancer Cells Implanted into Mice.  Saeki N, Ono H, Sakamoto H, Yoshida T.  Anticancer Res.  2015  35:2619-25  PubMed ID: 25964537
7466  rs2294008T, a risk allele for gastric and gallbladder cancers, suppresses the PSCA promoter by recruiting the transcription factor YY1.  Saeki N, Ono H, Yanagihara K, Aoyagi K, Sasaki H, Sakamoto H, Yoshida T.  Genes Cells  2015  20:382-91  PubMed ID: 25727947
7862  Gene expression analysis for predicting gemcitabine resistance in human cholangiocarcinoma.  Sato J, Kimura T, Saito T, Anazawa T, Kenjo A, Sato Y, Tsuchiya T, Gotoh M.  J Hepatobiliary Pancreat Sci  2011  18:700-11  PubMed ID: 21451941
8068  Nedd4L modulates the transcription of metalloproteinase-1 and -13 genes to increase the invasive activity of gallbladder cancer.  Takeuchi T, Adachi Y, Nagayama T, Furihata M.  Int J Exp Pathol  2010  92:79-86  PubMed ID: 21039987
10170  Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer.  Weber H, Valbuena JR, Barbhuiya MA, Stein S, Kunkel H, García P, Bizama C, Riquelme I, Espinoza JA, Kurtz SE, Tyner JW, Calderon JF, Corvalán AH, Grez M, Pandey A, Leal-Rojas P, Roa JC.  Oncotarget  2017  8:26169-26184  PubMed ID: 28412732
10222  MicroRNA-125b predicts clinical outcome and suppressed tumor proliferation and migration in human gallbladder cancer.  Yang L, Huang S, Ma H, Wu X, Feng F.  Tumour Biol.  2017  39:1010428317692249  PubMed ID: 28347246
4891  Screening for the FIG-ROS1 fusion in biliary tract carcinomas by nested PCR.  Peraldo Neia C, Cavalloni G, Balsamo A, Venesio T, Napoli F, Sassi F, Martin V, Frattini M, Aglietta M, Leone F.  Genes Chromosomes Cancer  2014  53(12):1033-40  PubMed ID: 25231053
3690  The ERK/MAPK pathway is overexpressed and activated in gallbladder cancer.  uchegger K, Silva R2, López J1, Ili C1, Araya JC3, Leal P2, Brebi P1, Riquelme I4, Roa JC5.  Pathol Res Pract.  2017  213(5):476-482  PubMed ID: 28285962
3694  Inhibition of SCAMP1 suppresses cell migration and invasion in human pancreatic and gallbladder cancer cells.  Yang S, Lee KT, Lee JY, Lee JK, Lee KH, Rhee JC.  Tumour Biol  2013  34(5):2731-9  PubMed ID: 2365338
3695  Missense allele of a single nucleotide polymorphism rs2294008 attenuated antitumor effects of prostate stem cell antigen in gallbladder cancer cells.  Ono H, Chihara D, Chiwaki F, Yanagihara K, Sasaki H, Sakamoto H, Tanaka H, Yoshida T, Saeki N, Matsuo K.  J Carcinog  2013  12:4  PubMed ID: 23599686
3696  Expression of receptor for advanced glycation end products (RAGE) in human biliary cancer cells.  Hirata K, Takada M, Suzuki Y, Kuroda Y.  Hepatogastroenterology  2003  50(53):1205-7  PubMed ID: 14571699
3699  Therapeutic efficacy of G207, a conditionally replicating herpes simplex virus type 1 mutant, for gallbladder carcinoma in immunocompetent hamsters.  Nakano K, Todo T, Chijiiwa K, Tanaka M.  Mol Ther  2001  3(4):431-7.  PubMed ID: 11319903
3700  Expression of homeodomain protein CDX2 in gallbladder carcinomas.  Wu XS, Akiyama Y, Igari T, Kawamura T, Hiranuma S, Shibata T, Tsuruta K, Koike M, Arii S, Yuasa Y.  J Cancer Res Clin Oncol  2005  131(5):271-8  PubMed ID: 15645288
3701  Relations of hTERT and β-Catenin Expression with Cell Growth and Invasion in Gallbladder Cell Line  DINGAng TONGSaixiong SUOTao  Clinical Medical Journal of China  2005   
3702  p38delta/MAPK13 as a diagnostic marker for cholangiocarcinoma and its involvement in cell motility and invasion.  Tan FL, Ooi A, Huang D, Wong JC, Qian CN, Chao C, Ooi L, Tan YM, Chung A, Cheow PC, Zhang Z, Petillo D, Yang XJ, Teh BT.  Int J Cancer  2010  126(10):2353-61  PubMed ID: 19816939
3703  Skp2 overexpression is a p27Kip1-independent predictor of poor prognosis in patients with biliary tract cancers.  Sanada T, Yokoi S, Arii S, Yasui K, Imoto I, Inazawa J.  Cancer Sci  2004  95(12):969-76  PubMed ID: 1559604
3705  Overexpression of beta3/gamma2 chains of laminin-5 and MMP7 in biliary cancer.  Oka T, Yamamoto H, Sasaki S, Ii M, Hizaki K, Taniguchi H, Adachi Y, Imai K, Shinomura Y.  World J Gastroenterol  2009  15(31):3865-73  PubMed ID: 19701966
3706  Lectin Microarray-Based Sero-Biomarker Verification Targeting Aberrant O-Linked Glycosylation on Mucin 1.  Matsuda A, Kuno A, Nakagawa T, Ikehara Y, Irimura T, Yamamoto M, Nakanuma Y, Miyoshi E, Nakamori S, Nakanishi H, Viwatthanasittiphong C, Srivatanakul P, Miwa M, Shoda J, Narimatsu H.  Anal Chem  2015  87(14):7274-81  PubMed ID: 26091356
3709  Overexpression and gene amplification of EGFR, HER2, and HER3 in biliary tract carcinomas, and the possibility for therapy with the HER2-targeting antibody pertuzumab.  Kawamoto T, Ishige K, Thomas M, Yamashita-Kashima Y, Shu S, Ishikura N, Ariizumi S, Yamamoto M, Kurosaki K, Shoda J.  J Gastroenterol  2015  50(4):467-79  PubMed ID: 25112701
3710  Verification of WFA-Sialylated MUC1 as a Sensitive Biliary Biomarker for Human Biliary Tract Cancer.  Yamaguchi T, Yokoyama Y, Ebata T, Matsuda A, Kuno A, Ikehara Y, Shoda J, Narimatsu H, Nagino M.  Ann Surg Oncol  2016  23(2):671-7  PubMed ID: 26416714
3711  Hepatocyte growth factor activator inhibitor type 1 suppresses metastatic pulmonary colonization of pancreatic carcinoma cells.  Fukushima T, Kawaguchi M, Yamasaki M, Tanaka H, Yorita K, Kataoka H.  Cancer Sci  2011  102(2):407-13  PubMed ID: 21166957
3712  Transcriptional silencing of Dickkopf gene family by CpG island hypermethylation in human gastrointestinal cancer.  Maehata T, Taniguchi H, Yamamoto H, Nosho K, Adachi Y, Miyamoto N, Miyamoto C, Akutsu N, Yamaoka S, Itoh F.  World J Gastroenterol  2008  14(17):2702-14  PubMed ID: 18461655
3713  Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.  Taniguchi H, Yamamoto H, Hirata T, Miyamoto N, Oki M, Nosho K, Adachi Y, Endo T, Imai K, Shinomura Y.  Oncogene  2005  24(53):7946-52  PubMed ID: 16007117
3714  Cancer detection by ubiquitin carboxyl-terminal esterase L1 methylation in pancreatobiliary fluids.  Kato N, Yamamoto H, Adachi Y, Ohashi H, Taniguchi H, Suzuki H, Nakazawa M, Kaneto H, Sasaki S, Imai K, Shinomura Y.  World J Gastroenterol  2013  19(11):1718-27  PubMed ID: 23555160
3715  Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid.  Idrees AS, Sugie T, Inoue C, Murata-Hirai K, Okamura H, Morita CT, Minato N, Toi M, Tanaka Y.  Cancer Sci  2013  104(5):536-42  PubMed ID: 23387443
3717  Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines.  Wada M, Yazumi S, Takaishi S, Hasegawa K, Sawada M, Tanaka H, Ida H, Sakakura C, Ito K, Ito Y, Chiba T.  Oncogene  2004  23(13):2401-7  PubMed ID: 14743205
3719  Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer.  van Haaften G et al  Nat Genet  2009  41(5):521-3  PubMed ID: 19330029
3720  Serum Wisteria Floribunda Agglutinin-Positive Sialylated Mucin 1 as a Marker of Progenitor/Biliary Features in Hepatocellular Carcinoma.  Tamaki N, Kuno A, Matsuda A, Tsujikawa H, Yamazaki K, Yasui Y, Tsuchiya K, Nakanishi H, Itakura J, Korenaga M, Mizokami M, Kurosaki M, Sakamoto M, Narimatsu H, Izumi N5.  Sci Rep  2017  7(1):244  PubMed ID: 28325920
3721  Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneity.  Li L, Knutsdottir H, Hui K, Weiss MJ, He J, Philosophe B, Cameron AM, Wolfgang CL, Pawlik TM, Ghiaur G, Ewald AJ, Mezey E, Bader JS, Selaru FM.  JCI Insight  2019  4(2)  PubMed ID: 30674722
3722  Insulin-like growth factor receptor expression is associated with aggressive phenotypes and has therapeutic activity in biliary tract cancers.  Ohashi H, Adachi Y, Yamamoto H, Taniguchi H, Nosho K, Suzuki H, Arimura Y, Imai K, Carbone DP, Shinomura Y.  Cancer Sci  2012  103(2):252-61  PubMed ID: 22044563
3723  Establishment and characterization of a novel highly aggressive gallbladder cancer cell line, TJ-GBC2.  Liu ZY, Xu GL, Tao HH, Yang YQ, Fan YZ.  Cancer Cell Int  2017  17:20  PubMed ID: 2819409
3724  Characteristics of a novel cell line ZJU-0430 established from human gallbladder carcinoma.  Zhou F, Zhang Y, Sun J, Yang X.  Cancer Cell Int  2019  19:190  PubMed ID: 31367188
6101  Prostate stem cell antigen, a presumable organ-dependent tumor suppressor gene, is down-regulated in gallbladder carcinogenesis.  Ono H, Hiraoka N, Lee YS, Woo SM, Lee WJ, Choi IJ, Saito A, Yanagihara K, Kanai Y, Ohnami S, Chiwaki F, Sasaki H, Sakamoto H, Yoshida T, Saeki N.  Genes Chromosomes Cancer.  2012  51(1):30-41  PubMed ID: 21936014
6319  Alpha-methylacyl coenzyme A racemase overexpression in gallbladder carcinoma confers an independent prognostic indicator.  Wu LC, Chen LT, Tsai YJ, Lin CM, Lin CY, Tian YF, Sheu MJ, Uen YH, Shiue YL, Wang YH, Yang SJ, Wu WR, Li SH, Iwamuro M, Kobayasshi N, Huang HY, Li CF.  J Clin Pathol  2012  65(4):309-14  PubMed ID: 22267983



Back Back Return Top Page